# Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission

> **NCT02605460** · PHASE2 · UNKNOWN · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 20 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia

## Interventions

- **DRUG:** Busulfan
- **DRUG:** Cyclophosphamide
- **DRUG:** CXCR4 Antagonist
- **PROCEDURE:** Hematopoietic Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT02605460
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2020-11
- **Final completion:** 2021-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02605460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02605460, "Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02605460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*